Literature DB >> 12180894

Dermatological care of the diabetic foot.

Mo Aye1, Ewan A Masson.   

Abstract

Approximately 30% of patients with diabetes mellitus will have disease-related dermatological problems. Dry skin can be associated with autonomic neuropathy and may be fragile, promoting bacterial invasion. Any potentially infected 'diabetic foot' must be taken seriously, and non-painful deep sepsis suspected if there is evidence of sensory loss. Consideration should be given to eliminating nasal carriage of staphylococci if recurrent superficial sepsis occurs in the presence of poor diabetic control. Fungal infections, both of skin and nails, are common but usually not serious in the absence of immunosuppression. Treatment with topical antifungals may need to be combined with systemic therapy for successful eradication. Systemic antifungal therapy should be carefully considered as treatment needs to be prolonged and is potentially toxic, particularly in individuals with diabetes mellitus who often have co-morbidities. Varicose eczema should be treated by physical therapies intended to improve venous return and prevent peripheral edema and tissue injury. Allergic dermatitis is commonly associated with topical treatments and other sensitizers. Many reactions are not apparent from history, and patch testing for sensitivity is recommended. There are several diabetes mellitus-specific conditions that dermatologists must be aware of, including, necrobiosis lipoidica diabeticorum, granuloma annulare, diabetic dermopathy (spotted leg syndrome or shin spots), diabetic bullae (bullosis diabeticorum), and limited joint mobility and waxy skin syndrome. Ulceration, due to varying combinations of peripheral vascular disease and sensory neuropathy, is the province of the specialist team dealing with the diabetic foot and should ideally be referred to an appropriate multidisciplinary team.

Entities:  

Mesh:

Year:  2002        PMID: 12180894     DOI: 10.2165/00128071-200203070-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  8 in total

1.  Knowledge, Attitudes, and Practices Associated With Diabetic Foot Prevention Among Rural Adults With Diabetes in North China.

Authors:  Huimin Jia; Xiaocheng Wang; Jingmin Cheng
Journal:  Front Public Health       Date:  2022-05-20

2.  Bullosis diabeticorum: rare presentation in a common disease.

Authors:  Vineet Gupta; Neha Gulati; Jaya Bahl; Jaswinder Bajwa; Naveen Dhawan
Journal:  Case Rep Endocrinol       Date:  2014-11-18

3.  Portable System for Monitoring the Microclimate in the Footwear-Foot Interface.

Authors:  José de Jesús Sandoval-Palomares; Javier Yáñez-Mendiola; Alfonso Gómez-Espinosa; José Martin López-Vela
Journal:  Sensors (Basel)       Date:  2016-07-08       Impact factor: 3.576

4.  Frequency of Cutaneous Fungal Infections and Azole Resistance of the Isolates in Patients with Diabetes Mellitus.

Authors:  Omid Raiesi; Mansour Siavash; Faezeh Mohammadi; Javaher Chabavizadeh; Behzad Mahaki; Mehrnoush Maherolnaghsh; Parvin Dehghan
Journal:  Adv Biomed Res       Date:  2017-06-06

5.  Pruritic vesicular eruption on the lower legs in a diabetic female.

Authors:  Hassan Riad; Hamda Al Ansari; Khaled Mansour; Haya Al Mannai; Hussein Al Sada; Samya Abu Shaikha; Sharifa Al Dosari
Journal:  Case Rep Dermatol Med       Date:  2013-10-01

Review 6.  Bullosis Diabeticorum: A Rare Presentation with Immunoglobulin G (IgG) Deposition Related Vasculopathy. Case Report and Focused Review.

Authors:  Hardik Sonani; Sohail Abdul Salim; Vishnu V Garla; Anna Wile; Venkataraman Palabindala
Journal:  Am J Case Rep       Date:  2018-01-15

7.  Bullous Diabeticorum: A Rare Blistering Manifestation of Diabetes.

Authors:  Debajyoti Chatterjee; Anshul Radotra; Bishan D Radotra; Sanjeev Handa
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug

8.  Trisk 95 as a novel skin mirror for normal and diabetic systemic glucose level.

Authors:  Nsrein Ali; Hamid Reza Rezvani; Diana Motei; Sufyan Suleman; Walid Mahfouf; Isabelle Marty; Veli-Pekka Ronkainen; Seppo J Vainio
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.